Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
PCR - Polymerase Chain Reaction01:32

PCR - Polymerase Chain Reaction

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same author

Characterization of CTNND2-related neurodevelopmental disease, phenotype-genotype spectrum and WNT dynamics in early neurogenesis.

Research square·2026
Same author

Clinical Value of MLPA for Prognostic Assessment of Chromosomal Rearrangements and DNA Methylation in Uveal Melanoma.

Investigative ophthalmology & visual science·2025
Same author

High-resolution repeat structure analysis in myotonic dystrophy type 2 diagnostics using short-read whole genome sequencing.

Analytical biochemistry·2025
Same author

Advancing molecular diagnostics of myotonic dystrophy type 1 using short-read whole genome sequencing.

Molecular and cellular probes·2024
Same author

Prognostic Value of Genotype-Phenotype Correlations in X-Linked Myotubular Myopathy and the Use of the Face2Gene Application as an Effective Non-Invasive Diagnostic Tool.

Genes·2023

Related Experiment Video

Updated: Jun 5, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing.

Jan Radvansky1, Andrej Ficek, Ludevit Kadasi

  • 1Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia. jradvanszky@gmail.com

Genetic Testing and Molecular Biomarkers
|January 6, 2011
PubMed
Summary

Tetraplet repeat-primed PCR (TP-PCR) is used for diagnosing myotonic dystrophy. Reversing the TP-PCR amplification direction improves results for DM2 diagnosis by providing clearer, more informative data.

More Related Videos

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Related Experiment Videos

Last Updated: Jun 5, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

Area of Science:

  • Genetics and Molecular Biology
  • Neuromuscular Disorders

Background:

  • Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are common adult autosomal dominant neuromuscular disorders.
  • DM1 and DM2 result from unstable repeat expansions in the DMPK and ZNF9 genes, respectively.
  • The ZNF9 gene in DM2 contains a complex motif with polymorphic elements, complicating genetic analysis.

Purpose of the Study:

  • To compare the effectiveness of tetraplet repeat-primed PCR (TP-PCR) in different amplification directions for DM1 and DM2 genetic analysis.
  • To determine if altering the TP-PCR direction can improve the quality and interpretability of results, particularly for DM2.

Main Methods:

  • Utilized repeat-primed polymerase chain reaction (PCR), specifically tetraplet repeat-primed PCR (TP-PCR).
  • Compared TP-PCR amplification in the standard direction (amplifying through TGn TCTGn) versus the opposite direction.
  • Analyzed results for repeat number, interruptions, and overall data quality for both DM1 and DM2.

Main Results:

  • TP-PCR is effective for detecting expanded alleles and characterizing repeat structures in DM1 and DM2.
  • Amplification in the direction excluding the TGn TCTGn tract yielded higher quality and more informative results compared to the standard direction.
  • The complex repeat motif in DM2 presents interpretation challenges, which are mitigated by the reversed TP-PCR approach.

Conclusions:

  • Reversing the TP-PCR amplification direction offers superior results for analyzing DM2-associated repeat sequences.
  • This optimized TP-PCR method enhances diagnostic accuracy and characterization of repeat structures in myotonic dystrophy patients.
  • The findings advocate for adopting the reversed TP-PCR strategy for more robust genetic testing in DM1 and DM2.